Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'268 1.4%  SPI 13'166 1.5%  Dow 28'726 -1.7%  DAX 12'114 1.2%  Euro 0.9672 1.0%  EStoxx50 3'318 1.2%  Gold 1'661 0.0%  Bitcoin 19'151 0.5%  Dollar 0.9876 1.2%  Öl 87.9 -1.1% 
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
08.08.2022 20:51:34

Why Global Blood Therapeutics Stock Was Trouncing the Market Today

Trading in Global Blood Therapeutics (NASDAQ: GBT) stock was lively on Monday, with the blood-disorder-focused biotech rising by over 4% over Friday's close by midafternoon today. That's hardly surprising, as the company struck a deal to be acquired by one of the hottest operators in the pharmaceutical sector.In a joint press release Monday morning, Global Blood Therapeutics and Pfizer (NYSE: PFE) announced that they have signed an agreement for the latter to purchase the former. The all-cash deal will see Pfizer acquire all outstanding shares of Global Blood Therapeutics for $68.50 per share; all told, the enterprise value of the arrangement is roughly $5.4 billion.The companies added that both their boards of directors have unanimously approved the deal.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.